CSS
Cubist Systematic Strategies Portfolio holdings
AUM $9.23B
1-Year Return
5.79%
This Quarter Return
+6.94%
1 Year Return
+5.79%
3 Year Return
+24.49%
5 Year Return
+69.08%
10 Year Return
+125.75%
AUM
$8.08B
AUM Growth
-$17.9M
(-0.22%)
Cap. Flow
-$768M
Cap. Flow
% of AUM
-9.51%
Top 10 Holdings %
Top 10 Hldgs %
6.66%
Holding
2,830
New
750
Increased
625
Reduced
628
Closed
593
Top Buys
| 1 |
Synopsys
SNPS
|
+$56.8M |
| 2 |
Micron Technology
MU
|
+$48.4M |
| 3 |
Schlumberger
SLB
|
+$42.9M |
| 4 |
Roku
ROKU
|
+$39.7M |
| 5 |
Starbucks
SBUX
|
+$38.9M |
Top Sells
| 1 |
McDonald's
MCD
|
+$77.4M |
| 2 |
Elevance Health
ELV
|
+$75.8M |
| 3 |
Adobe
ADBE
|
+$65.8M |
| 4 |
Nike
NKE
|
+$57.3M |
| 5 |
Salesforce
CRM
|
+$56.7M |
Sector Composition
| 1 | Technology | 22.3% |
| 2 | Consumer Discretionary | 17% |
| 3 | Healthcare | 12.33% |
| 4 | Industrials | 11.38% |
| 5 | Financials | 11.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Ramaco Resources Class A
METC
$1.72B
| $626K | ﹤0.01% |
+37,669
| New | +$626K |
|
1302
Zoetis
ZTS
$64.8B
| $624K | ﹤0.01% |
3,163
-54,153
| -94% | -$10.7M |
|
1303
Surgery Partners
SGRY
$2.77B
| $624K | ﹤0.01% |
+19,506
| New | +$624K |
|
|
PDM
1304
Piedmont Realty Trust, Inc.
PDM
$1.1B
| $620K | ﹤0.01% |
+87,186
| New | +$620K |
|
1305
Ingles Markets
IMKTA
$1.31B
| $618K | ﹤0.01% |
+7,159
| New | +$618K |
|
1306
QuantumScape
QS
$5.86B
| $616K | ﹤0.01% |
+88,704
| New | +$616K |
|
1307
Regenxbio
RGNX
$459M
| $615K | ﹤0.01% |
34,267
-36,918
| -52% | -$663K |
|
1308
Cognyte Software
CGNT
$617M
| $615K | ﹤0.01% |
95,575
+62,359
| +188% | +$401K |
|
1309
AudioCodes
AUDC
$290M
| $614K | ﹤0.01% |
50,888
-23,844
| -32% | -$288K |
|
1310
Lindsay Corp
LNN
$1.52B
| $613K | ﹤0.01% |
4,743
+2,414
| +104% | +$312K |
|
1311
HF Sinclair
DINO
$9.66B
| $612K | ﹤0.01% |
11,020
-177,612
| -94% | -$9.87M |
|
1312
Avanos Medical
AVNS
$569M
| $611K | ﹤0.01% |
+27,219
| New | +$611K |
|
1313
Expensify
EXFY
$176M
| $604K | ﹤0.01% |
244,537
+188,785
| +339% | +$466K |
|
1314
Vanda Pharmaceuticals
VNDA
$259M
| $603K | ﹤0.01% |
142,817
-76,493
| -35% | -$323K |
|
1315
Asbury Automotive
ABG
$4.77B
| $603K | ﹤0.01% |
+2,679
| New | +$603K |
|
1316
Matsons
MATX
$3.34B
| $601K | ﹤0.01% |
+5,488
| New | +$601K |
|
|
GRCL
1317
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
| $593K | ﹤0.01% |
59,063
+57,656
| +4,098% | +$579K |
|
1318
Saratoga Investment
SAR
$386M
| $593K | ﹤0.01% |
22,916
+6,811
| +42% | +$176K |
|
1319
Turning Point Brands
TPB
$1.86B
| $591K | ﹤0.01% |
22,472
-5,479
| -20% | -$144K |
|
1320
AstraZeneca
AZN
$242B
| $591K | ﹤0.01% |
8,778
-21,974
| -71% | -$1.48M |
|
1321
Wyndham Hotels & Resorts
WH
$6.42B
| $590K | ﹤0.01% |
+7,338
| New | +$590K |
|
1322
Monolithic Power Systems
MPWR
$40.7B
| $587K | ﹤0.01% |
931
-839
| -47% | -$529K |
|
1323
Cabot Corp
CBT
$4.2B
| $581K | ﹤0.01% |
6,954
-26,326
| -79% | -$2.2M |
|
1324
Intellia Therapeutics
NTLA
$1.24B
| $581K | ﹤0.01% |
19,042
-4,794
| -20% | -$146K |
|
1325
Cullinan Oncology
CGEM
$375M
| $580K | ﹤0.01% |
56,926
+24,294
| +74% | +$248K |
|